117 related articles for article (PubMed ID: 33298658)
1. [Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia].
Kumagai T; Doki N; Kobayashi T; Yamada R; Hishima T; Adachi H; Konuma R; Fujita M; Wada A; Kishida Y; Konishi T; Nagata A; Yamada Y; Kaito S; Yoshifuji K; Mukae J; Akiyama M; Inamoto K; Toya T; Igarashi A; Najima Y; Kakihana K; Sakamaki H; Ohashi K
Rinsho Ketsueki; 2020; 61(11):1625-1627. PubMed ID: 33298658
[TBL] [Abstract][Full Text] [Related]
2. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia.
Matsubara H; Makimoto A; Takayama J; Higa T; Saito T; Kanda Y; Tanosaki R; Mineishi S; Ohira M; Takaue Y
Jpn J Clin Oncol; 2001 Jan; 31(1):30-4. PubMed ID: 11256838
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
Mori A; Hashino S; Imamura M; Kahata K; Kawakami H; Shibata M; Kobayashi S; Tanaka J; Asaka M
Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
[TBL] [Abstract][Full Text] [Related]
4. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
5. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population.
Nagatoshi Y; Kawano Y; Watanabe T; Abe T; Okamoto Y; Kuroda Y; Takaue Y; Okamura J
Pediatr Transplant; 2002 Aug; 6(4):319-26. PubMed ID: 12234273
[TBL] [Abstract][Full Text] [Related]
8. [Pneumatosis intestinalis after allogeneic bone marrow transplantation for acute lymphocytic leukemia].
Noda M; Takeuchi Y; Tsujimoto T; Takimoto Y; Okita H
Rinsho Ketsueki; 2001 Sep; 42(9):696-700. PubMed ID: 11680981
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
10. Optic neuropathy associated with GVHD after bone marrow allogeneic hematopoietic stem cell transplantation for B-Acute lymphoblastic leukemia: case report.
Wang B; Jiang F; Wang X
BMC Ophthalmol; 2022 Mar; 22(1):97. PubMed ID: 35232408
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z
Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231
[TBL] [Abstract][Full Text] [Related]
13. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
14. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
[TBL] [Abstract][Full Text] [Related]
15. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation.
Kleinau I; Perez-Canto A; Schmid HJ; Grassot A; Staab D; Renz H; Henze G; Wahn U; Paul K
Bone Marrow Transplant; 1997 Apr; 19(8):841-4. PubMed ID: 9134179
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children.
Madero L; González Vincent M; Ramirez M; Quintero V; Benito A; Díaz MA
Bone Marrow Transplant; 2000 Aug; 26(3):269-73. PubMed ID: 10967564
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
20. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
